Related Experiment Video
Updated: Mar 30, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
Targeting fatty acid metabolism in cancer and endothelial cells
Ulrike Harjes1, Joanna Kalucka1, Peter Carmeliet1
1Laboratory of Angiogenesis and Neurovascular Link, Vesalius Research Center, Department of Oncology, University of Leuven, Leuven B-3000, Belgium; Laboratory of Angiogenesis and Neurovascular Link, Vesalius Research Center, VIB, Leuven B-3000, Belgium.
Abstract:
Tumour angiogenesis has long been recognised as a target for anti-cancer therapy. The current approach of inhibiting the VEGF pathway has shown benefit in the clinic, though less than anticipated. We recently documented that glycolytic metabolism in endothelial cells (ECs) fuels angiogenesis, rendering it a possible target for inhibiting vascular growth in pathological conditions. More recently, we reported that the oxidation of fatty acids (FA) is irreplaceable for EC proliferation by providing carbons for de novo nucleotide synthesis. Furthermore, ECs are rather unique in this respect, creating novel therapeutic opportunities. Here, we review and compare the current understanding of FA utilisation in ECs and tumour cells (TCs).
Insights
Endothelial cells (ECs) use fatty acid oxidation (FAO) for proliferation, offering new anti-cancer strategies. Targeting FAO in ECs may inhibit tumour angiogenesis more effectively than current therapies.
Area of Science:
- Cellular metabolism
- Cancer biology
- Angiogenesis
Background:
- Tumour angiogenesis is a validated anti-cancer target.
- VEGF pathway inhibition shows limited clinical efficacy.
- Endothelial cell (EC) metabolism is crucial for angiogenesis.
Purpose of the Study:
- To review and compare fatty acid (FA) utilization in ECs and tumour cells (TCs).
- To highlight novel therapeutic opportunities targeting EC metabolism.
Main Methods:
- Literature review of FA metabolism in ECs and TCs.
- Comparison of metabolic pathways.
Main Results:
- Glycolytic metabolism fuels EC angiogenesis.
- Fatty acid oxidation (FAO) is essential for EC proliferation, providing nucleotides.
- ECs uniquely utilize FAO for nucleotide synthesis.
Conclusions:
- Targeting EC FAO presents a novel therapeutic strategy for anti-angiogenesis therapy.
- Understanding FA utilization in ECs and TCs can inform future cancer treatments.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
The Tumor Microenvironment
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

